| | | | | |
| A$44,5448 | +0,27% | A$392,37M | A$25,84K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | A$19,6671 | -0,21% | A$391,89M | A$65,39K | |
TSI TCW Strategic Income Fund, Inc. | A$6,1267 | +0,46% | A$391,25M | A$357,72K | |
PAII Pyrophyte Acquisition Corp. II | A$14,3587 | +0,05% | A$390,56M | A$25,34K | |
| A$19,6252 | -4,10% | A$390,37M | A$547,50K | |
YDES YD Bio Limited Ordinary Shares | A$6,5044 | -0,85% | A$390,37M | A$24,55K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | A$13,9740 | +0,00% | A$389,87M | A$39,16 | |
RWAY Runway Growth Finance Corp. Common Stock | A$9,1901 | -1,05% | A$389,84M | A$541,66K | |
JILL J.Jill, Inc. Common Stock | A$27,9900 | -0,99% | A$389,83M | A$48,44K | |
LCTX Lineage Cell Therapeutics, Inc. | A$1,5247 | +0,93% | A$389,14M | A$806,89K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | A$14,4286 | +0,05% | A$389,03M | A$20,47K | |
ACV Virtus Diversified Income & Convertible Fund | A$37,0122 | -0,71% | A$388,99M | A$13,75K | |
ALXO ALX Oncology Holdings Inc. Common Stock | A$2,7766 | -2,70% | A$388,77M | A$340,23K | |
| A$1,9583 | -2,10% | A$388,63M | A$1,06M | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | A$4,1964 | +0,00% | A$388,39M | A$70,23K | |
